Theravance Biopharma, Inc. Inventory, Finished Goods, Net of Reserves
Theravance Biopharma, Inc. (TBPH) had Inventory, Finished Goods, Net of Reserves of $3.51 million as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2019-02-28
- 2018-09-30: Inventory, Finished Goods, Net of Reserves $3.51M.
- 2018-06-30: Inventory, Finished Goods, Net of Reserves $3.98M.
- 2018-03-31: Inventory, Finished Goods, Net of Reserves $4.62M.
- 2017-12-31: Inventory, Finished Goods, Net of Reserves $5.04M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2018-09-30 | $3.51M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $3.98M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $4.62M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $5.04M 10-K · filed 2019-02-28 |
| 2017-09-30 | $4.55M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.99M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $3.14M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.53M 10-K · filed 2018-02-28 |
| 2016-09-30 | $4.35M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $2.16M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $2.38M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $3.14M 10-K · filed 2017-03-01 |
| 2015-09-30 | $4.83M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $5.24M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $5.59M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $5.57M 10-K · filed 2016-03-11 |
| 2014-09-30 | $7.49M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $5.61M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $4.79M 10-Q · filed 2014-06-24 |
| 2013-12-31 | $4.91M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |